NVISION Eye Centers Among First Providers of Groundbreaking Treatment for Vision Loss

ORANGE COUNTY, CA and LAS VEGAS, NV--(Marketwired - Jun 10, 2015) - NVISION Eye Centers is pleased to announce a first-of-its-kind procedure from CentraSight, available to Las Vegas and Orange County, Calif. patients that utilizes a tiny telescope implant to treat end-stage age-related macular degeneration (AMD), the most advanced form of AMD and the leading cause of blindness in older Americans.

"Part of NVISION's mission is to improve the overall quality of life for our patients and allow them to see and experience the world like never before, and this new procedure does just that," said NVISION President James Pereyra. "These patients have lost a lot of hope and often isolate themselves from friends and family because of their loss of vision, so this treatment is not just vision-restoring, it's life-restoring."

AMD is the number-one cause of vision impairment in adults over the age of 60 and nearly 15 million seniors in the United States are battling severe vision loss because of the disease. Patients with end-stage AMD have a central blind spot or missing area in their vision that makes it difficult or impossible to see faces, read, and perform everyday activities. The CentraSight treatment program involves implanting a smaller-than-a-pea-sized telescope to magnify images and project them onto the healthy portion of the retina not affected by the disease, making it possible for patients to see or discern the central vision object of interest.

The procedure employs the expertise of a variety of medical professionals, including retina specialists, who confirm the AMD diagnosis; low-vision optometrists and occupational therapists, for pre- and post-op training and rehabilitation; and skilled surgeons, who perform the surgery.

"I am excited and honored that NVISION has been selected for the CentraSight team in Las Vegas," said Dr. Paul Casey, a leading ophthalmologist who practices at both of NVISION's Las Vegas offices and is part of CentraSight's initial care team. "This procedure will change the lives of so many people living with age-related macular degeneration."

The ideal candidates for the CentraSight procedure are patients over the age of 65, who meet specific health and eye condition requirements. If you or someone you know is a potential candidate for the procedure, please visit www.CentraSight.com or call 1-877-99SIGHT.

For more information about NVISION Eye Centers, please visit www.NVISIONCenters.com.

ABOUT CENTRASIGHT: CentraSight is a first-of-kind treatment program that utilizes a tiny telescope implant for End-stage age-related macular degeneration (AMD), the most advanced form of AMD and the leading cause of blindness in older Americans. Patients with end-stage AMD have a central blind spot or missing area in their vision that makes it difficult or impossible to see faces, read, and perform everyday activities. The CentraSight treatment program allows patients to see again by implanting a tiny telescope in the eye in an outpatient procedure, then coordinating with low vision specialists to help the patient learn how to use their new vision for everyday activities. To find out more, please go to www.CentraSight.com or call 1-877-99SIGHT.

ABOUT NVISION EYE CENTERS: NVISION Eye Centers is one of the leading providers of LASIK and cataract surgery in the U.S., with 18 centers in California, Nevada and Oregon. An innovative leader in ophthalmology, NVISION is dedicated to providing the best patient experience through the use of the latest technology and treatment by the most talented and experienced surgeons in the industry. NVISION was founded in 2010 by Tom Tooma, M.D., one of the earliest pioneers of LASIK who has performed more than 100,000 procedures throughout his esteemed career. With more than 1,700 eye doctors referring their patients and trusting their own eyes to NVISION surgeons, NVISION Eye Centers is the Eye Doctors' #1 Choice®. For more information, visit www.NVISIONCenters.com or call 877-91NVISION (877-916-8474).